Itoh D, Inoue K, Saito D, Hamaguchi K, Kaneko K, Sumita T, Inukai K, Inoue I, Shimada A. Effects of Dapagliflozin Compared with Sitagliptin and Metformin in Drug-Naïve Japanese Patients with Type 2 Diabetes: A 12-Week, Open-Label, Randomized, Active-Controlled Trial. Diabetes Ther. 2021 Dec;12(12):3201-3215.
Horii T*, Oikawa Y*, Atsuda K, Shimada A. On-label use of sodium-glucose cotransporter 2 inhibitors may increase the risk of diabetic ketoacidosis in patients with type 1 diabetes. J Diabetes Investig. 2021 Sep;12(9):1586-1593. (*: These authors contributed equally to this work.)
Nakano T, Aochi H, Masataka H, Takenaka Y, Fujita K, Tamura M, Soma H, Kamezawa H, Koizumi T, Shibuya H, Inomata R, Okuda A, Murakoshi T, Shimada A, Inoue I. Effects of Pparγ1 deletion on late-stage murine embryogenesis and cells that undergo endocycle. Dev Biol. 2021 Oct;478:222-235.
Chujo D, Imagawa A, Yasuda K, Abiru N, Awata T, Fukui T, Ikegami H, Kawasaki E, Katsuki T, Kobayashi T, Kozawa J, Nagasawa K, Ohtsu H, Oikawa Y, Osawa H, Shimada A, Shimoda M, Takahashi K, Tsuchiya K, Tsujimoto T, Yasuda H, Hanafusa T, Kajio H. Japanese Type 1 Diabetes Database Study (TIDE-J): rationale and study design. Diabetol Int. 2021 Sep 6;13(1):288-294.
Yasuda S, Inoue I, Shimada A. Neurofibromatosis Type 1 with Concurrent Multiple Endocrine Disorders: Adenomatous Goiter, Primary Hyperparathyroidism, and Acromegaly. Intern Med. 2021;60(15):2451-2459.
Kurokawa Y, Oikawa Y, Shimada A, Yajima K. Dupilumab-related type 1 diabetes in a patient with atopic dermatitis: a case report. Diabetol Int. 2021 Aug 10;13(1):300-303.
Sugawa SW, Yoshida Y, Hikima Y, Sato H, Shimada A, Noda M, Kushiyama A. Characteristics Associated with Early Worsening of Retinopathy in Patients with Type 2 Diabetes Diagnosed with Retinopathy at Their First Visit: A Retrospective Observational Study. J Diabetes Res. 2021 Jul 17;2021:7572326.
Kayamori Y, Nakamura M, Kishi K, Miida T, Nishimura K, Okamura T, Hirayama S, Ohmura H, Yoshida H, Ai M, Tanaka A, Sumino H, Murakami M, Inoue I, Teramoto T, Yokoyama S. Comparison of the Japan Society of Clinical Chemistry reference method and CDC methodfor HDL and LDL cholesterol measurements using fresh sera. Pract Lab Med. 2021 May;25:e00228.
Yamada Y, Sugi K, Gatate Y, Senbonmatsu T, Inoue I, Fukushima K, Iguchi A, Nakajima H, Muramatsu T, Nakano S, Tada H. Premature acute myocardial infarction in a young patient with sitosterolemia. CJC Open. 2021 May 4;3(8):1085-1088.
Yasuda S, Inoue K, Iida S, Oikawa Y, Namba A, Isshiki M, Inoue I, Kamei Y, Shimada A, Noda M. Differences in the birthweight of infants born to patients with early- or mid-to-late-detected gestational diabetes mellitus who underwent guideline-based glycemic control. J Diabetes Complications. 2021 Apr;35(4):107850.
Abiru N, Shimada A, Nishimura R, Matsuhisa M, Ozaki A, Ikegami H. Glycemic control status, diabetes management patterns, and clinical characteristics of adults with type 1 diabetes in Japan: Study of Adults’ Glycemia in T1DM subanalysis. Diabetol Int. 2021 Apr 25;12(4):460-473.
Sasako T, Ueki K, Miyake K, Okazaki Y, Takeuchi Y, Ohashi Y, Noda M, Kadowaki T. Effect of a multifactorial intervention on fracture in patients with type 2 diabetes: sub-analysis of the J-DOIT3 study. J Clin Endocrinol Metab. 2021 Apr 23;106(5):e2116-e2128.
Kawasaki E, Oikawa Y, Okada A, Kanatsuna N, Kawamura T, Kikuchi T, Terasaki J, Miura J, Ito Y, Hanafusa T. Different Interaction of Onset Age and Duration of Type 1 Diabetes on the Dynamics of Autoantibodies to IA-2 and ZnT8. J Diabetes Investig. 2021 Apr;12(4):510-515.
Sasako T, Ueki K, Miyake K, Okazaki Y, Takeuchi Y, Ohashi Y, Noda M, Kadowaki T. Effect of a Multifactorial Intervention on Fracture in Patients With Type 2 Diabetes: Subanalysis of the J-DOIT3 Study. J Clin Endocrinol Metab. 2021 Apr 23;106(5):e2116-e2128.
Koizumi T, Kaneda H, Komiyama N, Inoue I, Muramatsu T, Nakajima K. Lipoprotein Profiles before Heparin Administration in Patients with or without Coronary Thrombosis Following Atherosclerosis. Ann Vasc Dis. 2021 Mar 25;14(1):31-38.
Satomura A*, Oikawa Y*, Nakanishi S, Takagi S, Mizutani G, Iida S, Nakayama H, Haga Y, Nagata M, Maesaki S, Mimura T, Shimada A. Clinical features resembling subcutaneous insulin resistance observed in a patient with type 2 diabetes and severe COVID-19-associated pneumonia: a case report. Diabetol Int. 2021 Mar 1:1-6. (*: These authors contributed equally to this work.)
Ueki K, Sasako T, Okazaki Y, Miyake K, Nangaku M, Ohashi Y, Noda M, Kadowaki T; J-DOIT3 Study Group. Multifactorial intervention has a significant effect on diabetic kidney disease in patients with type 2 diabetes. Kidney Int. 2021 Jan;99(1):256-266.
Ueki K, Tanizawa Y, Nakamura J, Yamada Y, Inagaki N, Watada H, Shimomura I, Nishimura R, Miyoshi H, Abiko A, Katagiri H, Hayashi M, Shimada A, Naruse K, Fujimoto S, Fujiwara M, Shikata K, Okada Y, Araki E, Yamazaki T, Kadowaki T; J-BRAND Registry Group. Long-term safety and efficacy of alogliptin, a DPP-4 inhibitor, in patients with type 2 diabetes: a 3-year prospective, controlled, observational study (J-BRAND Registry). BMJ Open Diabetes Res Care. 2021 Jan;9(1):e001787.
Horii T, Oikawa Y, Kunisada N, Shimada A, Atsuda K. Real-world risk of hypoglycemia-related hospitalization in Japanese patients with type 2 diabetes using SGLT2 inhibitors: a nationwide cohort study. BMJ Open Diabetes Res Care. 2020 Nov;8(2):e001856.
Ikegami H, Imagawa A, Shimada A. Fulminant type 1 diabetes: nationwide effort to elucidate genetics, etiology, and pathogenesis since 2000. Diabetol Int. 2020 Oct;11(4):342-343.
Shimada A, Ikegami H. Twenty years since the discovery of fulminant type 1 diabetes. Diabetol Int. 2020 Oct;11(4):309.
Oikawa Y, Shimada A. Possible involvement of autoimmunity in fulminant type 1 diabetes. Diabetol Int. 2020 Oct;11(4):329–335.
Teratani T, Toma-Fukai S, Nakamura Y, Itoh T, Shimizu H, Shiraishi Y, Sugihara N, Higashiyama M, Shimizu T, Inoue I, Takenaka Y, Hokari R, Adachi T, Shimizu T, Miura S, Kanai T. Redox-dependent PPARγ/Tnpo1 complex formation enhances PPARγ nuclear. Free Radic Biol Med. 2020 Aug 20;156:45-56.
Nakano T, Inoue I, Takenaka Y, Ito R, Kotani N, Sato S, Nakano Y, Hirasaki M, Shimada A, Murakoshi T. Ezetimibe impairs transcellular lipid trafficking and induces large lipid droplet formation in intestinal absorptive epithelial cells. Biochim Biophys Acta Mol Cell Biol Lipids. 2020 Dec;1865(12):158808.
Wilunda C, Sawada N, Goto A, Yamaji T, Iwasaki M, Tsugane S, Noda M. Soy food and isoflavones are not associated with changes in serum lipids and glycohemoglobin concentrations among Japanese adults: a cohort study. Eur J Nutr. 2020 Aug;59(5):2075-2087.
Kikuchi H, Inoue S, Odagiri Y, Ihira H, Inoue M, Sawada N, Noda M, Tsugane S. Intensity-specific validity and reliability of the Japan Public Health Center-based prospective study-physical activity questionnaire. Prev Med Rep. 2020 Aug 6;20:101169.
Saito D, Nakajima R, Yasuda S. Examination of Malignant Findings of Thyroid Nodules Using Thyroid Ultrasonography. J Clin Med Res. 2020;12(8):499-507.
Isshiki M, Sakuma I, Hayashino Y, Sumita T, Hara K, Takahashi K, Shiojima I, Satoh-Asahara N, Kitazato H, Ito D, Saito D, Hatano M, Ikegami Y, Iida S, Shimada A, Noda M. Effects of dapagliflozin on renin-angiotensin-aldosterone system under renin-angiotensin system inhibitor administration. Endocr J. 2020 Nov 28;67(11):1127-1138.
Yamazaki C, Goto A, Iwasaki M, Sawada N, Oba S, Noda M, Iso H, Koyama H, Tsugane S. Body mass index and mortality among middle-aged Japanese individuals with diagnosed diabetes: The Japan Public Health Center-based prospective study (JPHC study). Diabetes Res Clin Pract. 2020 Jun;164:108198.
Yamazaki C, Goto A, Iwasaki M, Sawada N, Oba S, Noda M, Iso H, Koyama H, Tsugane S. Body mass index and mortality among middle-aged Japanese individuals with diagnosed diabetes: The Japan Public Health Center-based prospective study (JPHC study). Diabetes Res Clin Pract. 2020 Jun;164:108198.
Koba S, Inoue I, Cyrille M, Lu C, Inomata H, Shimauchi J, Kajinami K. Evolocumab vs. Ezetimibe in Statin-Intolerant Hyperlipidemic Japanese Patients: Phase 3 GAUSS-4 Trial. J Atheroscler Thromb. 2020 May 1;27(5):471-484.